Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombotic Therapy during Percutaneous Coronary Intervention.

Harrington1

  • 1Division of Cardiology, Duke University Medical Center, Durham, NC and Duke Databank for Cardiovascular Disease, Erwin Square, Bay A, 2024 West Main Street, Durham, NC 27705.

Journal of Thrombosis and Thrombolysis
|January 1, 1995
PubMed
Summary

Ischemic complications after percutaneous coronary intervention are common. Novel platelet and thrombin inhibitors may improve outcomes by targeting key players in arterial injury response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-Infection by HTLV-I/II is Associated With Increased Viral Load in PBMC of HIV-1 Infected Patients in Bahia, Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2000
Same author

Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study.

Cardiovascular radiation medicine·2000
Same author

Evaluation of neural network models with generalized sensitivity analysis

Analytical chemistry·2000
Same author

Clinical trials report

Current cardiology reports·2000
Same author

Occupational health: recognising and preventing work related disease and injury, 4th edition

Occupational and environmental medicine·2000
Same author

Platelet Inhibition in Cardiovascular Disease Management: Aspirin and Beyond.

Journal of thrombosis and thrombolysis·2000

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Hematology

Background:

  • Ischemic complications frequently limit percutaneous coronary intervention (PCI) success.
  • Platelets and thrombin are critical in arterial injury response and PCI-related ischemia.
  • Current treatments like aspirin and heparin are standard but have limitations.

Purpose of the Study:

  • To review the role of platelets and thrombin in PCI-induced ischemic complications.
  • To discuss the potential of novel antithrombotic agents in improving PCI outcomes.

Main Methods:

  • Literature review of studies on PCI complications, platelet function, and thrombin pathways.
  • Analysis of existing data on aspirin and heparin efficacy.
  • Evaluation of emerging data on novel thrombin and platelet inhibitors.

Related Experiment Videos

Main Results:

  • Platelets and thrombin are central to the pathophysiology of PCI-related ischemia.
  • Standard therapies (aspirin, heparin) are effective but do not eliminate ischemic events.
  • Novel inhibitors targeting specific platelet and thrombin pathways show promise.

Conclusions:

  • Understanding the role of platelets and thrombin is crucial for managing PCI complications.
  • Novel antithrombotic strategies offer potential for enhanced acute and long-term outcomes after PCI.
  • Further research into these novel agents is warranted to optimize clinical practice.